URETERAL NEOPLASMS

Clinical trials for URETERAL NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new URETERAL NEOPLASMS trials appear

Sign up with your email to follow new studies for URETERAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug targets genetic driver in advanced bladder cancer

Disease control Recruiting now

This early-stage study is testing a new drug called LOXO-435 for people with advanced solid tumors, including bladder cancer, that have a specific genetic change (FGFR3). The main goals are to find a safe dose, understand side effects, and see if the drug can shrink tumors. The s…

Matched conditions: URETERAL NEOPLASMS

Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

URETERAL NEOPLASMS

Get alerted when new URETERAL NEOPLASMS trials appear

New drug targets genetic driver in advanced bladder cancer